These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 6590017)

  • 61. Progesterone receptor loss identifies luminal-type local advanced breast cancer with poor survival in patients who fail to achieve a pathological complete response to neoadjuvant chemotherapy.
    Chen S; Huang L; Chen CM; Shao ZM
    Oncotarget; 2015 Jul; 6(20):18174-82. PubMed ID: 26053183
    [TBL] [Abstract][Full Text] [Related]  

  • 62. [Metastatic breast cancers: comparison of the prognostic significance and the sensitivity to chemotherapy according to the presence of estradiol and progesterone receptors].
    Pouillart P; Madgelenat H; Jouve M; Palangie T; Garcia-Giralt E; Bretaudeau B; Polijcak M; Asselain B
    Bull Cancer; 1982; 69(5):461-7. PubMed ID: 7165808
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Prognostic significances of estrogen and progesterone receptors in primary operable breast cancer.
    Kurebayashi J; Ishida T; Higashi Y; Suemasu K; Nomoto C; Yoshida K
    Jpn J Clin Oncol; 1990 Sep; 20(3):271-80. PubMed ID: 2255103
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Prognostic factors in primary breast cancer.
    McGuire WL
    Cancer Surv; 1986; 5(3):527-36. PubMed ID: 3555781
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Neoadjuvant chemotherapy of breast cancer: tumor markers as predictors of pathologic response, recurrence, and survival.
    Precht LM; Lowe KA; Atwood M; Beatty JD
    Breast J; 2010; 16(4):362-8. PubMed ID: 20443786
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Estrogen and progesterone receptor status of primary breast cancer: relationship with the pattern of first metastasis and survival.
    Bhatavdekar JM; Patel DD; Karelia NH; Trivedi SN; Shah NG; Vora HH; Ghosh N; Balar DB
    Neoplasma; 1992; 39(6):349-52. PubMed ID: 1491724
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Significance of estrogen and progesterone receptors, disease-free interval, and site of first metastasis on survival of breast cancer patients.
    Alanko A; Heinonen E; Scheinin T; Tolppanen EM; Vihko R
    Cancer; 1985 Oct; 56(7):1696-700. PubMed ID: 4027900
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Receptor discordance rate and its effects on survival in primary and recurrent breast cancer patients.
    Ilgun S; Sarsenov D; Erdogan Z; Ordu C; Celebi F; Nur Pilanci K; Ozturk A; Selamoglu D; Alco G; Aktepe F; Eralp Y; Tuzlali S; Ozmen V
    J BUON; 2016; 21(6):1425-1432. PubMed ID: 28039703
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Prolactin receptor does not correlate with oestrogen and progesterone receptors in primary breast cancer and lacks prognostic significance. Ten year results of the Naples adjuvant (GUN) study.
    De Placido S; Gallo C; Perrone F; Marinelli A; Pagliarulo C; Carlomagno C; Petrella G; D'Istria M; Delrio G; Bianco AR
    Br J Cancer; 1990 Oct; 62(4):643-6. PubMed ID: 2223582
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Prognostic and predictive factors in breast cancer.
    Bundred NJ
    Cancer Treat Rev; 2001 Jun; 27(3):137-42. PubMed ID: 11417963
    [TBL] [Abstract][Full Text] [Related]  

  • 71. [Progesterone receptors in breast cancer (author's transl)].
    Navarro Moreno MA; Pastor Ferrer MC; Carrera Font T; Planells Torres P; Bonnin Lafuente R; Rosel Soria P
    Med Clin (Barc); 1981 Sep; 77(4):158-61. PubMed ID: 7198174
    [No Abstract]   [Full Text] [Related]  

  • 72. Season of tumour detection influences factors predicting survival of patients with breast cancer.
    Mason BH; Holdaway IM; Stewart AW; Neave LM; Kay RG
    Breast Cancer Res Treat; 1990 Jan; 15(1):27-37. PubMed ID: 2328328
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Imprint cytology in immunocytochemical analysis of oestrogen and progesterone receptors of breast carcinoma.
    Helin HJ; Isola JJ; Helin MJ; Helle MJ; Krohn KJ
    J Clin Pathol; 1989 Oct; 42(10):1043-5. PubMed ID: 2685049
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hormone receptor measurements and survival in 1335 consecutive patients with primary invasive breast carcinoma.
    Raabe NK; Hagen S; Haug E; Fossaa SD
    Int J Oncol; 1998 May; 12(5):1091-6. PubMed ID: 9538134
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Estrogen receptor protein in breast cancer as a predictor of recurrence.
    Kinne DW; Ashikari R; Butler A; Menendez-Botet C; Rosen PP; Schwartz M
    Cancer; 1981 May; 47(10):2364-7. PubMed ID: 7272892
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Short recurrence-free survival associated with high oestrogen receptor levels in the natural history of postmenopausal, primary breast cancer.
    Thorpe SM; Christensen IJ; Rasmussen BB; Rose C
    Eur J Cancer; 1993; 29A(7):971-7. PubMed ID: 8499151
    [TBL] [Abstract][Full Text] [Related]  

  • 77. [Place of hormone receptor determination in the therapeutic strategy of breast cancer].
    Clavel B; Gest J
    Pathol Biol (Paris); 1983 Dec; 31(10):809-18. PubMed ID: 6366702
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The prognostic role of progesterone receptors in human breast cancer.
    McGuire WL; Clark GM
    Semin Oncol; 1983 Dec; 10(4 Suppl 4):2-6. PubMed ID: 6669985
    [TBL] [Abstract][Full Text] [Related]  

  • 79. [Reevaluation of indications for adjuvant hormone therapy in primary breast cancer with high metastatic risk].
    Martin PM; Romain S; Spyratos F; Spitalier JM; Ayme Y; Brandone H; Bressac C; Hans D; Jacquemier J; Hacene K
    Bull Cancer; 1991; 78(8):709-23. PubMed ID: 1932838
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Hormone receptors in male breast cancer.
    Mercer RJ; Bryan RM; Bennett RC
    Aust N Z J Surg; 1984 Jun; 54(3):215-8. PubMed ID: 6087783
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.